PortfoliosLab logoPortfoliosLab logo
ISIN
US74112D1019
CUSIP
74112D101
IPO Date
Feb 10, 2005

Highlights

Market Cap
$2.17B
Enterprise Value
$2.16B
EPS (TTM)
$3.91
PE Ratio
11.64
PEG Ratio
2.19
Total Revenue (TTM)
$1.09B
Gross Profit (TTM)
$595.58M
EBITDA (TTM)
$328.19M
Year Range
$42.62 - $84.70
Target Price
$66.00
ROA (TTM)
5.45%
ROE (TTM)
10.08%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Prestige Consumer Healthcare Inc.

Often compared with PBH:
PBH vs. HYGPBH vs. MWAPBH vs. SLF.TO

Performance

PBH Performance Chart

Prestige Consumer Healthcare Inc. (PBH) is down 26.3% since the beginning of the year. At $45 per share, PBH is trading 46.3% below its 52-week high of $85. Investors who bought $1,000 worth of PBH shares 5 years ago would now be looking at an investment worth $871.


Loading charts...

S&P 500 Index

Returns By Period

Prestige Consumer Healthcare Inc. (PBH) has returned -26.31% so far this year and -45.52% over the past 12 months. Over the last ten years, PBH has returned -1.55% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Prestige Consumer Healthcare Inc.

1D
-3.21%
1M
-5.29%
YTD
-26.31%
6M
-27.47%
1Y
-45.52%
3Y*
-7.38%
5Y*
-2.72%
10Y*
-1.55%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PBH Monthly Returns History

Based on dividend-adjusted daily data since Feb 10, 2005, PBH's average daily return is +0.05%, while the average monthly return is +0.88%. At this rate, an investment would double in approximately 6.6 years.

Historically, 53% of months were positive and 47% were negative. The best month was Dec 2008 with a return of +34.9%, while the worst month was Jul 2005 at -42.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.

On a daily basis, PBH closed higher 51% of trading days. The best single day was May 10, 2018 with a return of +23.7%, while the worst single day was Jul 28, 2005 at -40.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.51%7.49%-14.47%-4.98%-15.61%-4.36%-26.31%
2025-1.69%10.39%1.44%-5.51%5.47%-6.79%-7.39%-7.99%-8.29%-2.88%-1.73%3.59%-21.00%
20240.52%13.06%4.28%-1.10%-10.38%7.06%2.85%5.41%-3.40%2.29%14.94%-7.88%27.56%
20235.05%-8.38%3.95%-1.76%-6.99%3.84%9.73%-10.55%-1.95%3.79%-3.39%6.75%-2.20%
2022-6.92%5.46%-11.07%3.25%2.12%5.34%2.57%-16.13%-1.48%9.33%12.81%1.85%3.22%
202114.71%4.28%5.68%-1.18%14.49%4.47%0.86%9.21%-2.23%6.91%-6.73%8.40%73.93%

Benchmark Metrics

Prestige Consumer Healthcare Inc. has an annualized alpha of 2.83%, beta of 0.86, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since February 10, 2005.

  • This stock participated in 105.88% of S&P 500 Index downside but only 86.02% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
2.83%
Beta
0.86
0.19
Upside Capture
86.02%
Downside Capture
105.88%

Return for Risk

Risk / Return Rank

PBH ranks 2 for risk / return — in the bottom 2% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


PBH Risk / Return Rank: 22
Overall Rank
PBH Sharpe Ratio Rank: 00
Sharpe Ratio Rank
PBH Sortino Ratio Rank: 22
Sortino Ratio Rank
PBH Omega Ratio Rank: 22
Omega Ratio Rank
PBH Calmar Ratio Rank: 22
Calmar Ratio Rank
PBH Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Prestige Consumer Healthcare Inc. (PBH) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PBHBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-3.55

Sortino ratioReturn per unit of downside risk

-4.95

Omega ratioGain probability vs. loss probability

0.71

1.37

-0.66

Calmar ratioReturn relative to maximum drawdown

-0.99

2.78

-3.77

Martin ratioReturn relative to average drawdown

-1.65

12.44

-14.09

Dividends

Dividend History


Prestige Consumer Healthcare Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Prestige Consumer Healthcare Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Prestige Consumer Healthcare Inc. was 80.60%, occurring on Mar 11, 2009. Recovery took 935 trading sessions.

The current Prestige Consumer Healthcare Inc. drawdown is 48.97%.


Related event

Drawdown

Fall

Recovery

Underwater

Financial crisis2007–2009
-80.60%Mar 2009
3y 8mo3y 8mo
7y 4moJul 2005 - Nov 2012
2019 bear market2019
-53.75%Mar 2019
2y 9d2y 4mo
4y 5moMar 2017 - Aug 2021
2026 bear market2026
-49.00%Jun 2026
1y 15d
1y 1moMay 2025 - now
2014 bear market2014
-27.12%Feb 2014
1mo 11d9mo 3d
10mo 14dDec 2013 - Nov 2014
Bear market2022
-23.03%Sep 2022
10mo 19d2mo 6d
1y 20dNov 2021 - Dec 2022

Drawdown Indicators


PBHBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-80.60%

-56.78%

-23.82%

Max Drawdown (1Y)

Largest decline over 1 year

-46.33%

-9.10%

-37.23%

Max Drawdown (3Y)

Largest decline over 3 years

-49.00%

-18.90%

-30.10%

Max Drawdown (5Y)

Largest decline over 5 years

-49.00%

-25.43%

-23.57%

Max Drawdown (10Y)

Largest decline over 10 years

-53.75%

-33.92%

-19.83%

Current Drawdown

Current decline from peak

-48.97%

-1.80%

-47.17%

Average Drawdown

Average peak-to-trough decline

-28.04%

-10.71%

-17.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.67%

2.03%

+25.64%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Prestige Consumer Healthcare Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Prestige Consumer Healthcare Inc. is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PBH, comparing it with other companies in the Medical Distribution industry. Currently, PBH has a P/E ratio of 11.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for PBH compared to other companies in the Medical Distribution industry. PBH currently has a PEG ratio of 2.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PBH relative to other companies in the Medical Distribution industry. Currently, PBH has a P/S ratio of 2.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PBH in comparison with other companies in the Medical Distribution industry. Currently, PBH has a P/B value of 1.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with PBH

Add Prestige Consumer Healthcare Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with PBH